Milo-Cotter Olga, Cotter Gad, Kaluski Edo, Rund Michele M, Felker G Michael, Adams Kirkwood F, O'Connor Christopher M, Weatherley Beth Davison
Momentum Research Inc., 3100 Tower Blvd, Suite 802, Durham, NC 27707, USA.
Cardiology. 2009;114(1):75-82. doi: 10.1159/000213051. Epub 2009 Apr 17.
The risk stratification of patients with acute heart failure (AHF) has been addressed repeatedly in recent years. Low oxygen saturation (SaO2) and systolic blood pressure (SBP) are signs of impending respiratory and circulatory failure that can be obtained quickly in patients with AHF.
Admissions for AHF (340 patients) in a city hospital were recorded and patients were followed for symptoms of heart failure, re-admission and mortality for 6 months.
Patients with low (<90%) SaO2 had higher rates of worsening heart failure at 1 month and 6 months (p < 0.001 and p < 0.001, respectively) and higher rates of mortality (p = 0.013). SBP <120 mm Hg was not associated with a significant increase in worsening heart failure, but was associated with a statistically significant increase in mortality at 1 and 6 months (p < 0.001 and p < 0.001, respectively). Combined low SaO2 and SBP had a particularly strong prognostic implication. Patients who developed frank respiratory failure and/or circulatory failure fared the worst. Patients requiring ventilatory support had a recurrent heart failure rate of 81% and a mortality of 41% at 1 month of follow-up. Patients requiring intravenous pressors without respiratory mechanical support had a recurrent heart failure rate of 72% and a mortality rate of 28% at 1 month (p < 0.001).
Simple assessment of impending respiratory and circulatory failure at admission by measuring SaO2 and SBP enables rapid and accurate risk stratification of patients admitted for AHF. This may enable more aggressive therapeutic interventions for stabilization and treatment of AHF.
近年来,急性心力衰竭(AHF)患者的风险分层问题已被多次探讨。低氧饱和度(SaO2)和收缩压(SBP)是即将发生呼吸和循环衰竭的体征,在AHF患者中可快速获取。
记录一家城市医院收治的AHF患者(340例),并对患者进行为期6个月的心力衰竭症状、再次入院和死亡率随访。
SaO2低(<90%)的患者在1个月和6个月时心力衰竭恶化率较高(分别为p < 0.001和p < 0.001),死亡率也较高(p = 0.013)。收缩压<120 mmHg与心力衰竭恶化的显著增加无关,但与1个月和6个月时死亡率的统计学显著增加有关(分别为p < 0.001和p < 0.001)。低SaO2和SBP联合具有特别强的预后意义。发生明显呼吸衰竭和/或循环衰竭的患者预后最差。需要通气支持的患者在随访1个月时心力衰竭复发率为81%,死亡率为41%。需要静脉使用升压药但无需呼吸机械支持的患者在1个月时心力衰竭复发率为72%,死亡率为28%(p < 0.001)。
通过测量SaO2和SBP对入院时即将发生的呼吸和循环衰竭进行简单评估,能够对AHF入院患者进行快速准确的风险分层。这可能有助于对AHF进行更积极的治疗干预以实现病情稳定和治疗。